Green tea health claim
This article was originally published in The Tan Sheet
Executive Summary
FDA gives itself a three-month extension to make its decision on a qualified health claim petition linking daily green tea consumption to reduced risk of certain kinds of cancer; Trumbull, Conn.-based Fleminger submitted the petition. The purpose of the extension is "to allow more time for review of the petition and does not suggest any particular outcome of our decision on the petition," FDA says. The agency now will announce the decision on Jan. 28...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.